DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
11. 重症筋無力症
Myasthenia gravis
Clinical trials
/
Disease details
臨床試験数
:
332
/
薬物数
:
234
- (
DrugBank
:
81
) /
標的遺伝子数
:
45
-
標的パスウェイ数
:
127
Search
1 trial found
10
50
100
ALL
diseases per page:
Showing 1 to 1 of 1 diseases
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
EUCTR2020-005762-34-PL
(
EUCTR
)
15/07/2021
04/03/2021
Cladribine
therapy in Myasthenia
A phase 2 clinical trial assessing the efficacy and safety of adding
cladribine
for treatment modifying course of seropositive myasthenia gravis
A phase 2 clinical trial assessing the efficacy and safety of adding
cladribine
for treatment modifyi ...
Myasthenia gravis
MedDRA version: 21.1;Level: PT;Classification code 10028417;Term: Myasthenia gravis;System Organ Class: 10029205 - Nervous system disorders;Therapeutic area: Diseases [C] - Immune System Diseases [C20]
Myasthenia gravis
MedDRA version: 21.1;Level: PT;Classification code 10028417;Term: Myasthenia gravi ...
Product Name:
Cladrybine
INN or Proposed INN:
CLADRIBINE
Medical University of Lublin
NULL
Authorised-recruitment may be ongoing or finished
Female: yes
Male: yes
200
Phase 2
Poland